Sunovion Pharmaceuticals Inc (SEPR:US)
was acquired by 4005:JP
Sunovion Pharmaceuticals, Inc. manufactures pharmaceutical products. The Company develops and produces medicines for the treatment of central nervous system and respiratory ailments such as schizophrenia, depression, epilepsy, neuropathic pain, and insomnia. Sunovion Pharmaceuticals operates in the United States.